Experiments done in Sidney Strickland’s Laboratory of Neurobiology and Genetics at Rockefeller University in New York have identified a compound that might halt the progression of Alzheimer’s by interfering with the role amyloid-β, a small protein that forms plaques in Alzheimer’s brains, plays in the formation of blood clots. This work is highlighted in the July 2014 issue of Nature Reviews Drug Discovery.